Eli Lilly Ends Covid-19 Antibody Trial After Finding It’s Unlikely To Help Hospitalized Patients

Eli Lilly said it is ‘confident’ the therapy might prevent progression for people in earlier stages of the virus.

Read the full post on Forbes - Healthcare